Hari Srinivasan

Hari Srinivasan

Active Director Director DIN 00331017
DIN 00331017 First appointment May 2013 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 6 active board seats
Total affiliations 6 Since May 2013
Shareholding value •••• Premium profile

About Hari Srinivasan

Data last updated:

Hari Srinivasan is a Director at Garbha Gudi Ivf Centre Private Limited (since 2013), Director at Garbha Gudi Pharma Private Limited (since 2018) and Director at Garbhagudi Institute Of Reproductive Health And Research Private Limited (since 2019), and holds 3 more current directorships. The companies operate in Healthcare, Pharma and Financial Services. The 4 current companies with reported revenue have a combined latest revenue of ₹83.76 Cr; the largest is Garbha Gudi Ivf Centre Private Limited at ₹63.67 Cr (FY 2025).

DIN 00331017
Primary Designation Director
Industry Healthcare
First Appointment 10 May 2013
Oldest Company Age 15 yrs
Largest company Garbha Gudi Ivf Centre Private Limited · ₹63.67 Cr (FY 2025)
Combined revenue ₹83.76 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 May 20132011₹63.67 Cr (FY 2025)Active
Garbha Gudi Pharma Private Limited U85320KA2018PTC119713
Director20 Dec 20182018₹17.77 Cr (FY 2024)Active
Director09 Jan 20192019₹2.33 Cr (FY 2024)Active
Stratist Private Limited U74999KA2020PTC141336
Director23 Nov 20202020₹10,993 (FY 2025)Active
Thryva Life Private Limited U86900KA2025PTC204304
Director18 Jun 20252025Active
Walls Research Private Limited U63119KA2023PTC171165
Director13 Mar 20232023Active

Directorship timeline

Open interactive timeline →
Walls Research Private Limited
Stratist Private Limited
Garbhagudi Institute Of Reproductive Health And Research Private Limited
Garbha Gudi Ivf Centre Private Limited
Premium access

Shareholding and investment profile for Hari Srinivasan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hari Srinivasan

Hari Srinivasan currently holds 6 directorships: Garbha Gudi Ivf Centre Private Limited (Director, since 10 May 2013, revenue ₹63.67 Cr (FY 2025)); Garbha Gudi Pharma Private Limited (Director, since 20 Dec 2018, revenue ₹17.77 Cr (FY 2024)); Garbhagudi Institute Of Reproductive Health And Research Private Limited (Director, since 09 Jan 2019, revenue ₹2.33 Cr (FY 2024)); Stratist Private Limited (Director, since 23 Nov 2020, revenue ₹10,993 (FY 2025)); Thryva Life Private Limited (Director, since 18 Jun 2025); and 1 more.

Hari Srinivasan was first appointed on 10 May 2013 as Director at Garbha Gudi Ivf Centre Private Limited. The most recent appointment on record is 18 Jun 2025 at Thryva Life Private Limited.

The 4 current companies of Hari Srinivasan that report revenue have a combined latest revenue of ₹83.76 Cr: Garbha Gudi Ivf Centre Private Limited ₹63.67 Cr (FY 2025); Garbha Gudi Pharma Private Limited ₹17.77 Cr (FY 2024); Garbhagudi Institute Of Reproductive Health And Research Private Limited ₹2.33 Cr (FY 2024); Stratist Private Limited ₹10,993 (FY 2025).

The current boards of Hari Srinivasan's companies include Mattikerea Satyanarayana Pushpalatha (Garbha Gudi Ivf Centre Private Limited), Srinivasan Vijay Asha (Garbha Gudi Ivf Centre Private Limited), Vijay Kumar Seshadri (Garbha Gudi Ivf Centre Private Limited), Rahul Palamtharayil Radhakrishnan (Stratist Private Limited), Manjunath Venkata Raju (Thryva Life Private Limited), Juhi Tiwari (Walls Research Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available